Molecular detection of fluoroquinolone-resistance in multi-drug resistant tuberculosis in Cambodia suggests low association with XDR phenotypes

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Surcouf, Corinne ^a   Heng, Seiha ^a   Pierre Audigier, Catherine ^b   Cadet Daniel, Véronique ^b   Namouchi, Amine ^b   Murray, Alan ^b   Gicquel, Brigitte ^b   Guillard, Bertrand ^a  

^a INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ISONIAZID; KANAMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN; BACTERIAL DNA; DNA DIRECTED RNA POLYMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); QUINOLONE DERIVATIVE; RNA POLYMERASE BETA SUBUNIT; TUBERCULOSTATIC AGENT;

ANALYTICAL EQUIPMENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATE; CAMBODIA; CONTROLLED STUDY; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GYRA GENE; MOLECULAR DIAGNOSIS; MTBDR ASSAY; MULTIDRUG RESISTANT TUBERCULOSIS; NONHUMAN; PHENOTYPIC VARIATION; RPOB GENE; RRS GENE; SPOLIGOTYPING; STRAIN DIFFERENCE; CHEMISTRY; DNA SEQUENCE; DRUG EFFECT; EVALUATION; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE;

ANTITUBERCULAR AGENTS; CAMBODIA; DNA GYRASE; DNA, BACTERIAL; DNA-DIRECTED RNA POLYMERASES; FLUOROQUINOLONES; GENES, BACTERIAL; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 80053347593     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-255     Document Type: Article

References (35)

1. 2010 Wr Global tuberculosis control. 2010, 2010 Wr.
2. Organization. WH GLobal tuberculosis control: epidemiology, strategy, financing. WHO/HTM/TB/2009.411. Geneva, Switzerland: WHO, 2009. WHO report 2009, Organization. WH.
3. Yamada N, Saorith K, Yamakami K, Onozaki I, Boran S, Fujiki A, Eang MT, Mori T. The national tuberculosis drug resistance survey in Cambodia, 2000-2001. Int J Tuberc Lung Dis 2007, 11(12):1321-1327.
4. Sar B, Keo C, Leng C, Saman M, Min DC, Chan S, Monchy D, Sarthou JL. Anti-tuberculosis drug resistance and HIV co-infection in Phnom Penh, Cambodia. Southeast Asian J Trop Med Public Health 2009, 40(1):104-107.
5. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, Bunschoten A, Molhuizen H, Shaw R, Goyal M, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997, 35(4):907-914. 229700, 9157152.
6. Sekiguchi J, Miyoshi-Akiyama T, Augustynowicz-Kopec E, Zwolska Z, Kirikae F, Toyota E, Kobayashi I, Morita K, Kudo K, Kato S, et al. Detection of multidrug resistance in Mycobacterium tuberculosis. J Clin Microbiol 2007, 45(1):179-192. 10.1128/JCM.00750-06, 1828975, 17108078.
7. Sreevatsan S, Pan X, Stockbauer KE, Connell ND, Kreiswirth BN, Whittam TS, Musser JM. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc Natl Acad Sci USA 1997, 94(18):9869-9874. 10.1073/pnas.94.18.9869, 23284, 9275218.
8. Minime-Lingoupou F, Pierre-Audigier C, Kassa-Kelembho E, Barilone N, Zandanga G, Rauzier J, Cadet-Daniel V, Le Faou A, Gicquel B. Rapid identification of multidrug-resistant tuberculosis isolates in treatment failure or relapse patients in Bangui, Central African Republic. Int J Tuberc Lung Dis 14(6):782-785.
9. Ando H, Mitarai S, Kondo Y, Suetake T, Sekiguchi JI, Kato S, Mori T, Kirikae T. Pyrazinamide resistance in multidrug-resistant Mycobacterium tuberculosis isolates in Japan. Clin Microbiol Infect 16(8):1164-1168.
10. Louw GE, Warren RM, Donald PR, Murray MB, Bosman M, Van Helden PD, Young DB, Victor TC. Frequency and implications of pyrazinamide resistance in managing previously treated tuberculosis patients. Int J Tuberc Lung Dis 2006, 10(7):802-807.
11. Riska PF, Jacobs WR, Alland D. Molecular determinants of drug resistance in tuberculosis. Int J Tuberc Lung Dis 2000, 4(2 Suppl 1):S4-10.
12. 2010, http://www.moleculartb.org
13. Zhang H, Bi LJ, Li CY, Sun ZG, Deng JY, Zhang XE. Mutations found in the pncA gene of Mycobacterium tuberculosis in clinical pyrazinamide-resistant isolates from a local region of China. J Int Med Res 2009, 37(5):1430-1435.
14. Zignol M, Hosseini MS, Wright A, Weezenbeek CL, Nunn P, Watt CJ, Williams BG, Dye C. Global incidence of multidrug-resistant tuberculosis. J Infect Dis 2006, 194(4):479-485. 10.1086/505877, 16845631.
15. Xu C, Kreiswirth BN, Sreevatsan S, Musser JM, Drlica K. Fluoroquinolone resistance associated with specific gyrase mutations in clinical isolates of multidrug-resistant Mycobacterium tuberculosis. J Infect Dis 1996, 174(5):1127-1130. 10.1093/infdis/174.5.1127, 8896523.
16. Kocagoz T, Hackbarth CJ, Unsal I, Rosenberg EY, Nikaido H, Chambers HF. Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra. Antimicrob Agents Chemother 1996, 40(8):1768-1774. 163415, 8843279.
17. Huang TS, Kunin CM, Shin-Jung Lee S, Chen YS, Tu HZ, Liu YC. Trends in fluoroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwanese medical centre: 1995-2003. J Antimicrob Chemother 2005, 56(6):1058-1062. 10.1093/jac/dki353, 16204341.
18. Xu P, Li X, Zhao M, Gui X, DeRiemer K, Gagneux S, Mei J, Gao Q. Prevalence of fluoroquinolone resistance among tuberculosis patients in Shanghai, China. Antimicrob Agents Chemother 2009, 53(7):3170-3172. 10.1128/AAC.00177-09, 2704692, 19364851.
19. Brossier F, Veziris N, Jarlier V, Sougakoff W. Performance of MTBDR plus for detecting high/low levels of Mycobacterium tuberculosis resistance to isoniazid. Int J Tuberc Lung Dis 2009, 13(2):260-265.
20. Grimaldo ER, Tupasi TE, Rivera AB, Quelapio MI, Cardano RC, Derilo JO, Belen VA. Increased resistance to ciprofloxacin and ofloxacin in multidrug-resistant mycobacterium tuberculosis isolates from patients seen at a tertiary hospital in the Philippines. Int J Tuberc Lung Dis 2001, 5(6):546-550.
21. Bozeman L, Burman W, Metchock B, Welch L, Weiner M. Fluoroquinolone susceptibility among Mycobacterium tuberculosis isolates from the United States and Canada. Clin Infect Dis 2005, 40(3):386-391. 10.1086/427292, 15668861.
22. Balabanova Y, Ruddy M, Hubb J, Yates M, Malomanova N, Fedorin I, Drobniewski F. Multidrug-resistant tuberculosis in Russia: clinical characteristics, analysis of second-line drug resistance and development of standardized therapy. Eur J Clin Microbiol Infect Dis 2005, 24(2):136-139. 10.1007/s10096-004-1268-4, 15666160.
23. Hillemann D, Rusch-Gerdes S, Richter E. Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol 2009, 47(6):1767-1772. 10.1128/JCM.00081-09, 2691112, 19386845.
24. Kiet VS, Lan NT, An DD, Dung NH, Hoa DV, van Vinh Chau N, Chinh NT, Farrar J, Caws M. Evaluation of the MTBDRsl test for detection of second-line-drug resistance in Mycobacterium tuberculosis. J Clin Microbiol 48(8):2934-2939.
25. Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L, Horsburgh CR. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med 1993, 328(8):527-532. 10.1056/NEJM199302253280802, 8426619.
26. Telzak EE, Sepkowitz K, Alpert P, Mannheimer S, Medard F, el-Sadr W, Blum S, Gagliardi A, Salomon N, Turett G. Multidrug-resistant tuberculosis in patients without HIV infection. N Engl J Med 1995, 333(14):907-911. 10.1056/NEJM199510053331404, 7666876.
27. Conde MB, Efron A, Loredo C, De Souza GR, Graca NP, Cezar MC, Ram M, Chaudhary MA, Bishai WR, Kritski AL, et al. Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial. Lancet 2009, 373(9670):1183-1189. 10.1016/S0140-6736(09)60333-0, 2866651, 19345831.
28. Rustomjee R, Lienhardt C, Kanyok T, Davies GR, Levin J, Mthiyane T, Reddy C, Sturm AW, Sirgel FA, Allen J, et al. A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. Int J Tuberc Lung Dis 2008, 12(2):128-138.
29. Moadebi S, Harder CK, Fitzgerald MJ, Elwood KR, Marra F. Fluoroquinolones for the treatment of pulmonary tuberculosis. Drugs 2007, 67(14):2077-2099. 10.2165/00003495-200767140-00007, 17883288.
30. Wang JY, Lee LN, Lai HC, Wang SK, Jan IS, Yu CJ, Hsueh PR, Yang PC. Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure. J Antimicrob Chemother 2007, 59(5):860-865. 10.1093/jac/dkm061, 17412727.
31. Yu MC, Wu MH, Jou R. Extensively drug-resistant tuberculosis, Taiwan. Emerg Infect Dis 2008, 14(5):849-850. 10.3201/eid1405.071398, 2600264, 18439381.
32. Udwadia ZF, Jain S, Rodrigues C, Mehta A. XDR tuberculosis in India: what's in a name?. Lancet Infect Dis 2007, 7(7):441-442. 10.1016/S1473-3099(07)70141-X, 17597565.
33. Mokrousov I, Filliol I, Legrand E, Sola C, Otten T, Vyshnevskaya E, Limeschenko E, Vyshnevskiy B, Narvskaya O, Rastogi N. Molecular characterization of multiple-drug-resistant Mycobacterium tuberculosis isolates from northwestern Russia and analysis of rifampin resistance using RNA/RNA mismatch analysis as compared to the line probe assay and sequencing of the rpoB gene. Res Microbiol 2002, 153(4):213-219. 10.1016/S0923-2508(02)01311-6, 12066892.
34. Mokrousov I, Narvskaya O, Otten T, Limeschenko E, Steklova L, Vyshnevskiy B. High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001. Antimicrob Agents Chemother 2002, 46(5):1417-1424. 10.1128/AAC.46.5.1417-1424.2002, 127151, 11959577.
35. Mokrousov I, Otten T, Vyazovaya A, Limeschenko E, Filipenko ML, Sola C, Rastogi N, Steklova L, Vyshnevskiy B, Narvskaya O. PCR-based methodology for detecting multidrug-resistant strains of Mycobacterium tuberculosis Beijing family circulating in Russia. Eur J Clin Microbiol Infect Dis 2003, 22(6):342-348. 10.1007/s10096-003-0944-0, 12783278.